DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Baird Downgrades Teladoc Health to Neutral, Announces $130 Price Target

Baird analyst Matthew Gillmor downgrades Teladoc Health (NYSE:TDOC) from Outperform to Neutral and announces $130 price target.

Benzinga · 03/12/2020 09:24

Baird analyst Matthew Gillmor downgrades Teladoc Health (NYSE:TDOC) from Outperform to Neutral and announces $130 price target.